These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25499449)

  • 41. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
    Mihăilă RG
    World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular lymphoma: today's treatments and tomorrow's targets.
    Aurora V; Winter JN
    Expert Opin Pharmacother; 2006 Jul; 7(10):1273-90. PubMed ID: 16805715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transformation of follicular lymphoma - Why does it happen and can it be prevented?
    Link BK
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):49-56. PubMed ID: 29452666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of malignant low-grade lymphoma. Follicular Lymphoma Study Group].
    Solal-Celigny P
    Rev Med Interne; 1998; 19 Suppl 1():18S-20S. PubMed ID: 9789523
    [No Abstract]   [Full Text] [Related]  

  • 46. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
    Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
    Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
    [No Abstract]   [Full Text] [Related]  

  • 47. Rituximab maintenance versus radio-immunotherapy consolidation in first remission follicular non-Hodgkin lymphoma.
    Hagenbeek A
    Transfus Apher Sci; 2013 Aug; 49(1):43. PubMed ID: 23932512
    [No Abstract]   [Full Text] [Related]  

  • 48. Rituxan immunotherapy and zevalin radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
    White CA
    Curr Pharm Biotechnol; 2003 Aug; 4(4):221-38. PubMed ID: 14529425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphosarcoma. Treatment and end results in 355 patients.
    Molander DW
    Am J Roentgenol Radium Ther Nucl Med; 1973 Jan; 117(1):54-8. PubMed ID: 4119564
    [No Abstract]   [Full Text] [Related]  

  • 50. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
    Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
    Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
    Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New developments in immunotherapy for non-Hodgkin's lymphoma.
    Leonard JP; Furman RR; Ruan J; Coleman M
    Curr Oncol Rep; 2005 Sep; 7(5):364-71. PubMed ID: 16091197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD 30-positive transformed follicular lymphoma: two case reports and literature review.
    Montes-Moreno S; Climent F; González de Villambrosía S; González Barca EM; Batlle A; Insunza A; Pané-Foix M; Colorado M; Martin-Sánchez G; Espiga CR; Conde E; Piris MA
    Histopathology; 2015 Dec; 67(6):918-22. PubMed ID: 25953530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-Hodgkin's lymphoma: the old and the new.
    Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there a role for "watch and wait" in follicular lymphoma in the rituximab era?
    Kahl B
    Hematology Am Soc Hematol Educ Program; 2012; 2012():433-8. PubMed ID: 23233615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?
    Gisselbrecht C
    Hematology Am Soc Hematol Educ Program; 2012; 2012():410-6. PubMed ID: 23233612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma.
    Sarkozy C; Seymour JF; Ferme C; Caballero D; Ghesquieres H; Leppa S; Delarue R; Pedersen LM; Mounier C; Gomes Da Silva M; Chassagne-Clement C; Maerevoet M; Salles G
    Blood; 2014 Apr; 123(17):2740-2. PubMed ID: 24764560
    [No Abstract]   [Full Text] [Related]  

  • 60. [Recent therapeutic strategy for follicular lymphoma].
    Ogura M
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):787-804. PubMed ID: 17506321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.